Skip to main navigation
Skip to search
Skip to main content
Sort by
Pharmacology, Toxicology and Pharmaceutical Science
Metabolic Syndrome X
100%
Prevalence
61%
Risperidone
50%
Clozapine
50%
Alanine Aminotransferase
41%
Antipsychotic
39%
Adverse Event
38%
Typical Antipsychotic
31%
Bipolar Disorder
30%
Remission
28%
Positive Syndrome
26%
Negative Syndrome
26%
Monotherapy
25%
Amisulpride
25%
Liraglutide
25%
Aripiprazole
25%
Prolactin
25%
Side Effect
10%
Comorbidity
5%
Nausea
5%
Metabolic Disorder
5%
Neuroscience
Typical Antipsychotic
53%
Bipolar Disorder
50%
Aripiprazole
25%
Risperidone
25%
Major Depressive Disorder
25%
Transaminase
25%
Escitalopram
25%
Promoter Region
25%
Leptin
25%
Hallucination
25%
AKT1
25%
Negative Syndrome
25%
Alanine Aminotransferase
25%
Clozapine
25%
5,10 Methylenetetrahydrofolate Reductase (FADH2)
25%
Adiponectin
16%
Positive Syndrome
15%
Antipsychotic
14%
Meta-Analysis
12%
Resistin
11%
Antidepressant
10%
High Density Lipoprotein Cholesterol
8%
Triacylglycerol
8%
Bipolar I Disorder
8%
Body Mass Index
8%
Metabolic Pathway
6%
Folate
6%
Folic Acid
6%
Placebo
6%
Bipolar II Disorder
5%
Individual Differences
5%
Comorbidity
5%
Structural Equation Modeling
5%
Psychology
Metabolic Syndrome
100%
Schizophrenia
100%
Bipolar Disorder
31%
Hallucination
25%
Empathy
25%
Self-Report
18%
Depression
18%
Construct Validity
12%
Impulsivity
12%
Gaussian Distribution
8%
Rating Scale
6%
Personality Trait
6%
Meta-Analysis
6%
Mood
6%
Mania Rating Scale
6%
Wechsler Adult Intelligence Scale
6%
Comorbidity
5%
